Total Payments
$118,739
2019 Payments
$117,914
Companies
3
Transactions
26
Payment Breakdown by Category
Research$111,787 (94.1%)
Consulting$4,400 (3.7%)
Travel$1,598 (1.3%)
Food & Beverage$906.52 (0.8%)
Gifts$47.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $111,787 | 1 | 94.1% |
| Consulting Fee | $4,400 | 1 | 3.7% |
| Travel and Lodging | $1,598 | 10 | 1.3% |
| Food and Beverage | $906.52 | 13 | 0.8% |
| Gift | $47.00 | 1 | 0.0% |
Payments by Type
Research
$111,787
1 transactions
General
$6,952
25 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $111,787 | 1 | $0 (2019) |
| US WorldMeds, LLC | $6,127 | 16 | $0 (2019) |
| Alkermes, Inc. | $824.48 | 9 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $117,914 | 17 | Allergan Inc. ($111,787) |
| 2017 | $824.48 | 9 | Alkermes, Inc. ($824.48) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2019 | Allergan Inc. | VRAYLAR (Drug) | — | Cash or cash equivalent | $111,787.13 | Research |
| Study: A randomized, single-blind, placebo-controlled phase II study to assess the effects of cariprazine on brain and behavior in subjects with cocaine use disorder • Category: NEUROSCIENCE | ||||||
| 08/07/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Travel and Lodging | Cash or cash equivalent | $289.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 08/07/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Food and Beverage | In-kind items and services | $125.93 | General |
| Category: Psychiatry/Psychology | ||||||
| 08/07/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Food and Beverage | In-kind items and services | $115.48 | General |
| Category: Psychiatry/Psychology | ||||||
| 08/07/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Food and Beverage | In-kind items and services | $109.68 | General |
| Category: Psychiatry/Psychology | ||||||
| 08/07/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Food and Beverage | In-kind items and services | $61.21 | General |
| Category: Psychiatry/Psychology | ||||||
| 08/07/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Travel and Lodging | Cash or cash equivalent | $50.29 | General |
| Category: Psychiatry/Psychology | ||||||
| 08/07/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Travel and Lodging | Cash or cash equivalent | $47.87 | General |
| Category: Psychiatry/Psychology | ||||||
| 08/07/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Food and Beverage | In-kind items and services | $38.05 | General |
| Category: Psychiatry/Psychology | ||||||
| 08/07/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Psychiatry/Psychology | ||||||
| 08/07/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Food and Beverage | In-kind items and services | $7.31 | General |
| Category: Psychiatry/Psychology | ||||||
| 08/06/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Travel and Lodging | Cash or cash equivalent | $131.75 | General |
| Category: Psychiatry/Psychology | ||||||
| 08/03/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Consulting Fee | Cash or cash equivalent | $4,400.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 08/02/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Food and Beverage | In-kind items and services | $128.60 | General |
| Category: Psychiatry/Psychology | ||||||
| 07/01/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Travel and Lodging | Cash or cash equivalent | $165.76 | General |
| Category: Psychiatry/Psychology | ||||||
| 06/25/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Travel and Lodging | Cash or cash equivalent | $398.09 | General |
| Category: Psychiatry/Psychology | ||||||
| 06/25/2019 | US WorldMeds, LLC | Lucemyra/Lofexidine (Drug) | Travel and Lodging | Cash or cash equivalent | $39.32 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/27/2017 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Travel and Lodging | In-kind items and services | $152.00 | General |
| Category: CNS | ||||||
| 11/27/2017 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Travel and Lodging | In-kind items and services | $59.00 | General |
| Category: CNS | ||||||
| 11/02/2017 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Travel and Lodging | In-kind items and services | $265.19 | General |
| Category: CNS | ||||||
| 11/02/2017 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $104.98 | General |
| Category: CNS | ||||||
| 11/02/2017 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $93.80 | General |
| Category: CNS | ||||||
| 11/02/2017 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $68.75 | General |
| Category: CNS | ||||||
| 11/02/2017 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: CNS | ||||||
| 11/02/2017 | Alkermes, Inc. | Vivitrol 380 mg (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: CNS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A randomized, single-blind, placebo-controlled phase II study to assess the effects of cariprazine on brain and behavior in subjects with cocaine use disorder | Allergan Inc. | $111,787 | 1 |
About Dr. Kyle Kampman, MD
Dr. Kyle Kampman, MD is a Psychiatry healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093745085.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kyle Kampman, MD has received a total of $118,739 in payments from pharmaceutical and medical device companies, with $117,914 received in 2019. These payments were reported across 26 transactions from 3 companies. The most common payment nature is "" ($111,787).
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Addiction Psychiatry
- Location Philadelphia, PA
- Active Since 07/04/2006
- Last Updated 08/10/2015
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1093745085
Products in Payments
- VRAYLAR (Drug) $111,787
- Lucemyra/Lofexidine (Drug) $6,127
- Vivitrol 380 mg (Drug) $824.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Philadelphia
Daniel Weintraub, Md, MD
Psychiatry — Payments: $614,211
Psychiatry $614,211
Dr. Michael Thase, Md, MD
Psychiatry — Payments: $418,426
Psychiatry $418,426
Dr. Karl Doghramji, Md, MD
Psychiatry — Payments: $130,409
Psychiatry $130,409
Richard Jaffe, Md, MD
Psychiatry — Payments: $126,747
Psychiatry $126,747
Ramesh Eluri, M.d, M.D
Psychiatry — Payments: $88,982
Psychiatry $88,982
John Lauriello, Md, MD
Psychiatry — Payments: $75,274
Psychiatry $75,274